The Characteristics of Course of Pregnancy and Perinatal Outcomes in Women with Gestation Diabetes Mellitus (The Results of Ten-Years Research)

Abstract


The gestational diabetes mellitus is defined as disorder of glucose tolerance that is first detected during pregnancy. The purpose of the study was to investigate course and outcomes of pregnancy in pregnant women with gestational diabetes mellitus over 10 years. The analysis of course of pregnancy, childbirth and condition of newborns of 2363 women with gestational diabetes mellitus, observed in Ivanovo antenatal clinics in 2014–2023, was carried out. The analysis established increasing of rate of such complications as threatened early miscarriage, threatened late miscarriage, cervical insufficiency, toxicosis of pregnancy, anemia, chronic arterial hypertension, gestational arterial hypertension, moderate and severe preeclampsia, eclampsia, placental insufficiency, fetal growth restriction syndrome, chronic intrauterine fetal hypoxia, polyhydramnios, intrauterine fetal death, placenta previa, premature separation of normally located placenta, diabetic fetopathy. The childbirth was complicated by prenatal rupture of amniotic fluid, weakness of labor, dis-coordination of labor, clinically narrow pelvis, shoulder dystocia, and operative delivery. In newborns, congenital malformations, renal pyelectasia, and respiratory distress syndrome were diagnosed. The connecting-link between organism of mother and developing fetus is placenta. The various changes affecting maternal organism, including hyperglycemia, continue in formation of adverse events especially in placenta and subsequent development of negative complications and outcomes of pregnancy.

About the authors

N. V. Batrak

The Federal State Budget Educational Institution of Higher Education “The Ivanovo State Medical University” of the Minzdrav of Russia, 153012, Ivanovo, Russia

I. V. Ivanova

The Federal State Budget Educational Institution of Higher Education “The Ivanovo State Medical University” of the Minzdrav of Russia, 153012, Ivanovo, Russia

References

  1. Lee J., Lee N. K., Moon J. H. Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications. Endocrinol. Metab. (Seoul). 2025;40(1):10—25. doi: 10.3803/EnM.2024.2264
  2. Kim K. S., Hong S., Han K., Park C. Y. The clinical characteristics of gestational diabetes mellitus in Korea: a national health information database study. Endocrinol Metab (Seoul). 2021;36:628—36. doi: 10.3803/EnM.2020.948
  3. Wang H., Li N., Chivese T., Werfalli M., Sun H., Yuen L. IDF Diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by international association of diabetes in pregnancy study group’s criteria. Diabetes Res. Clin. Pract. 2022;183:109050. doi: 10.1016/j.diabres.2021.109050
  4. Moon J. H., Jang H. C. Gestational diabetes mellitus: diagnostic approaches and maternal-offspring complications. Diabetes Metab. J. 2022;46:3—14. doi: 10.4093/dmj.2021.0335
  5. Won S., Kim H., Park J., Oh K., Choi S., Jang H. Quality of life in women with gestational diabetes mellitus and treatment satisfaction upon intermittently scanned continuous glucose monitoring. J Korean Med. Sci. 2025;40:e46. doi: 10.3346/jkms.2025.40.e46
  6. Chung H. R., Moon J. H., Lim J. S., Lee Y. A., Shin C. H., Hong J. S., et al. Maternal hyperglycemia during pregnancy increases adiposity of offspring. Diabetes Metab. J. 2021;45:730—8. doi: 10.4093/dmj.2020.0154
  7. Aldahmash W. M., Alwasel S. H., Aljerian K. Gestational diabetes mellitus induces placental vasculopathies. Environ. Sci. Pollut. Res. Int. 2022;29(13):19860—8. doi: 10.1007/s11356-021-17267-y
  8. Owen M. D., Kennedy M. G., Quilang R. C., Scott E. M., Forbes K. The role of microRNAs in pregnancies complicated by maternal diabetes. Clin Sci (Lond). 2024;138(18):1179—207. doi: 10.1042/CS20230681
  9. Pan X., Jin X., Wang J., Hu Q., Dai B. Placenta inflammation is closely associated with gestational diabetes mellitus. Am. J. Transl. Res. 2021;13(5):4068—79.
  10. Fisher J. J., Vanderpeet C. L., Bartho L. A., McKeating D. R., Cuffe J. S. M., Holland O. J., et al. Mitochondrial dysfunction in placental trophoblast cells experiencing gestational diabetes mellitus. J. Physiol. 2021;599(4):1291—305. doi: 10.1113/JP280593
  11. Nguyen-Ngo C., Jayabalan N., Haghvirdizadeh P., Salomon C., Lamppas M. Role of adipose tissue in regulating fetal growth in gestational diabetes mellitus. Placenta. 2020;102:39—48. doi: 10.1016/j.placent.2020.05.006
  12. Kim W., Park S. K., Kim Y. L. Fetal abdominal obesity detected at 24 to 28 weeks of gestation persists until delivery despite management of gestational diabetes mellitus. Diabetes Metab. J. 2021;45:547—57. doi: 10.4093/dmj.2020.0078
  13. Moon J. H., Won S., Won H., Son H., Oh T. J., Kwak S. H. Metabolic Phenotypes of Women with Gestational Diabetes Mellitus Affect the Risk of Adverse Pregnancy Outcomes. Endocrinol. Metab. (Seoul). 2025;40(2):247—57. doi: 10.3803/EnM.2024.2089
  14. Immanuel J., Simmons D., Harreiter J., Desoye G., Corcoy R., Adelantado J. M., et al. Metabolic phenotypes of early gestational diabetes mellitus and their association with adverse pregnancy outcomes. Diabet Med. 2021;38:e14413. doi: 10.1111/dme.14413
  15. Wang N., Song L., Sun B., Peng Y., Fei S., Cui J. Contribution of gestational diabetes mellitus heterogeneity and prepregnancy body mass index to large-for-gestational-age infants: a retrospective case-control study. J. Diabetes. 2021;13:307—17. doi: 10.1111/1753-0407.13113
  16. Yang F., Liu H., Ding C. Gestational diabetes mellitus and risk of neonatal respiratory distress syndrome: a systematic review and meta-analysis. Diabetol. Metab. Syndr. 2024;16(1):294. doi: 10.1186/s13098-024-01539-x
  17. Yildiz Atar H., Baatz J. E., Ryan R. M. Molecular Mechanisms of Maternal Diabetes Effects on Fetal and Neonatal Surfactant. Children (Basel). 2021;8(4):281. doi: 10.3390/children8040281
  18. Saucedo R., Ortega-Camarillo C., Ferreira-Hermosillo A., Díaz-Velázquez M. F., Meixueiro-Calderón C., Valencia-Ortega J. Role of oxidative stress and inflammation in gestational diabetes mellitus. Antioxidants. 2023;12(10):1812. doi: 10.3390/antiox12101812
  19. Fasoulakis Z., Koutras A., Antsaklis P., Theodora M., Valsamaki A., Daskalakis G. Intrauterine Growth Restriction Due to Gestational Diabetes: From Pathophysiology to Diagnosis and Management. Medicina (Kaunas). 2023;59(6):1139. doi: 10.3390/medicina59061139
  20. Zhang L., Li K., Tian S., Wang X.-Q., Li J.-H., Dong Y.-C., et al. Down-regulation of microRNA-30d-5p is associated with gestational diabetes mellitus by targeting RAB8A. J. Diabetes Compl. 2021;35(8):107959. doi: 10.1016/j.jdiacomp.2021.107959
  21. Shah K. B., Chernausek S. D., Teague A. M., Bard D. E., Tryggestad J. B. Maternal diabetes alters microRNA expression in fetal exosomes, human umbilical vein endothelial cells and placenta. Pediatr. Res. 2021;89:1157—63. doi: 10.1038/s41390-020-1060-x
  22. Chen X., Yang F., Zhang T., Wang W., Xi W., Li Y., et al. MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma. J. Exp. Clin. Cancer Res. 2019;38:99. doi: 10.1186/s13046-019-1078-2
  23. Li W., Yuan X., He X., Yang L., Wu Y., Deng X., The downregulation of miR-22 and miR-372 may contribute to gestational diabetes mellitus through regulating glucose metabolism via the PI3K/AKT/GLUT4 pathway. J. Clin. Lab. Anal. 2022;36(7):e24557. doi: 10.1002/jcla.24557
  24. Hou L. J., Han J. J., Liu Y. Up-regulation of microRNA-503 by high glucose reduces the migration and proliferation but promotes the apoptosis of human umbilical vein endothelial cells by inhibiting the expression of insulin-like growth factor-1 receptor. Eur. Rev. Med. Pharmacol. Sci. 2018;22(11):3515—23. doi: 10.26355/eurrev_201806_15178
  25. Joshi N. P., Mane A. R., Sahay A. S., Sundrani D. P., Joshi S. R., Yajnik C. S. Role of Placental Glucose Transporters in Determining Fetal Growth. Reprod Sci. 2022;29(10):2744—59. doi: 10.1007/s43032-021-00699-9
  26. Napso T., Zhao X., Lligona M. I., Sandovici I., Kay R. G., George A. L., et al. Placental secretome characterization identifies candidates for pregnancy complications. Commun. Biol. 2021;4:701. doi: 10.1038/s42003-021-02214-x
  27. Yang Y., Guo F., Peng Y., Chen R., Zhou W., Wang H. Transcriptomic profiling of human placenta in gestational diabetes mellitus at the single-cell level. Front. Endocrinol (Lausanne). 2021;12:679582. doi: 10.3389/fendo.2021.679582
  28. Jiao B., Wang Y., Li S., Lu J., Liu J., Xia J., et al. Dissecting human placental cells heterogeneity in preeclampsia and gestational diabetes using single-cell sequencing. Mol. Immunol. 2023;161:104—18. doi: 10.1016/j.molimm.2023.07.005
  29. El Hajj N., Pliushch G., Schneider E., Dittrich M., Muller T., Korenkov M. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes. 2013;62:1320—8. doi: 10.2337/db12-0289
  30. Xie Y., Zhou W., Tao X., Lv H., Cheng Z. Early gestational blood markers to predict preeclampsia complicating gestational diabetes mellitus. Diabetes Metab. Syndr. Obes. 2023;16:1493—503. doi: 10.2147/DMSO.S410912

Statistics

Views

Abstract - 4

PDF (Russian) - 3

Cited-By


PlumX

Dimensions


Copyright (c) 2025 АО "Шико"

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Vorontsovo Pole, 12, Moscow

Email: ttcheglova@gmail.com

Phone: +7 903 671-67-12

Principal Contact

Tatyana Sheglova
Head of the editorial office
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Phone: +7 903 671-67-12
Email: redactor@journal-nriph.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies